May 11, 2022
TOPIC: Press Releases, Advocacy
NORD Applauds Congressional Efforts to Restore Intent of the Orphan Drug Act
Posted at May 5, 2022 04:42 pm by Rohan Narayanan
Washington, DC — The National Organization for Rare Disorders (NORD) applauds efforts of Congressional leaders to protect the Orphan Drug Act (ODA) and ensure proper incentives are in place to continue to foster robust rare disease drug development. Last week, leaders of the House Energy and Commerce Committee included language in their bipartisan Food and Drug Amendments… Read More